Earning CallsStock Market NewsStocks News
Trending

Johnson & Johnson Earnings Release: Q4 2021 – sales growth of 11.6%

Johnson & Johnson Earnings Release: Q4 2021

Johnson & Johnson (NYSE: JNJ) today announced results for the fourth quarter and full-year 2021. “Our 2021 performance reflects continued strength across all segments of our business. Guided by Our Credo, I am honored to assume the role of CEO, leading our global teams in continuing our work to deliver life-changing solutions to consumers, patients, and health care providers” said Joaquin Duato, Chief Executive Officer. “Given our strong results, financial profile, and innovative pipeline we are well-positioned for success in 2022 and beyond.”

2021 Fourth-Quarter Sales of $24.8 Billion reflecting growth of 10.4%, operational sales growth of 11.6%, and adjusted operational sales growth of 12.3%
• 2021 Full-Year Sales of $93.8 Billion reflecting growth of 13.6%, operational sales growth of 12.2%, and adjusted operational sales growth of 12.8%
• 2021 Fourth-Quarter EPS of $1.77 increased 172.3%; adjusted EPS of $2.13 increased 14.5%*
• 2021 Full-Year EPS of $7.81 increased 41.7%; adjusted EPS of $9.80 increased 22.0%*
• Company guides 2022 adjusted operational sales growth of 7.7%* and adjusted operational EPS growth of 9.2%*

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button

Welcome to The Finance Headline

Adblocker Detected! Please turn off your adblocker extension app to continue reading the articles/financial news. With your support, The Finance Headline is able to provide free resources.